Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.